Fueled by advances in emerging technologies such as precision medicine,[1] ultra-targeted therapies, “omics,”[2] and many more, the global biotechnology and genomics sector is expected to expand at a double-digit growth rate going forward. Having understood the potential of the sector, governments across the world are making concerted efforts to harness and develop their own biotechnology industries.